主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ICCC
#3451
Immucell Corp
6.4
0
+0.79%
版块:
基础:
利润货币:
日范围
年范围
日变化
+0.79%
每月变动
+0.63%
6个月变化
+4.40%
年变化
+21.67%
前一天收盘价
6.3
5
Open
6.4
0
Bid
Ask
Low
6.4
0
High
6.4
0
交易量
3
市场
股票
医疗保健
ICCC
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
7.22 M
7.74 M
7.75 M
7.75 M
8.98 M
—
Valuation ratios
Enterprise value
36.01 M
51.76 M
44.41 M
60.1 M
46.01 M
204.41 M
Price to earnings ratio
42.5
-800.01
-20.25
-6.67
-19.81
-86.37
Price to sales ratio
2.8
3.16
2.7
2.22
1.59
7.13
Price to cash flow ratio
32.62
63.66
-32.51
-8.29
117.52
199.16
Price to book ratio
1.52
1.86
1.65
1.55
1.53
2.9
Enterprise value to EBITDA ratio
37.25
19.04
1 125.28
-19.98
42.22
83.53
Profitability ratios
Return on assets %
0.03
-0
-0.06
-0.13
-0.05
0.05
Return on equity %
0.04
-0
-0.08
-0.23
-0.08
0.08
Return on invested capital %
18.3
3.66
-26.46
-59.17
-15.87
21.66
Gross margin %
44.73
44.98
41.19
22.15
29.97
164.75
Operating margin %
9
1.34
-12.38
-32.9
-6.19
31.07
EBITDA margin %
6.3
14.13
0.21
-17.22
4.11
72.01
Net margin %
6.66
-0.41
-13.43
-33.05
-8.14
29.82
Liquidity ratios
Quick ratio
4.55
5.2
2.59
0.92
1.8
7.76
Current ratio
5.5
6.42
4.56
2.78
3.41
15.59
Inventory turnover
3.68
4.09
2.39
1.96
2.49
—
Asset turnover
0.39
0.45
0.42
0.39
0.6
0.61
Solvency ratios
Debt to assets ratio
—
—
—
0.51
—
—
Debt to equity ratio
—
—
—
0.89
—
—
Long term debt to total assets ratio
0.22
0.19
0.2
0.27
0.23
0.81
Long term debt to total equity ratio
0.31
0.26
0.3
0.48
0.38
1.28
Per share metrics
Operating cash flow per share
0.18
0.13
-0.2
-0.6
0.04
0.22
EBIT per share
-0.19
0.03
-0.32
-0.74
-0.2
0.27
EBITDA per share
0.13
0.36
0.01
-0.39
0.13
0.58
Total debt per share
—
—
—
2.88
—
—
Cash per share
1.1
1.34
0.75
0.13
0.03
0.52
Net current asset value per share
1.69
2.14
1.81
1.51
1.84
7.37
Tangible book value per share
3.89
4.27
3.9
3.21
3.36
13.15
Working capital per share
1.38
1.81
1.41
0.97
1.3
5.47
Book value per share
3.92
4.29
3.92
3.23
3.37
13.2
新闻
ImmuCell董事将在2026年年度股东大会上卸任,董事会预计将发生变动
ImmuCell directors to step down at 2026 annual meeting, board changes expected
ImmuCell宣布新高管雇佣协议及期权授予
ImmuCell announces new executive employment agreements and option grants
Niche Focus & Regulation Shape the Future of Healthcare Firms
ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript
盈利电话会议记录:ImmuCell 2025年第四季度股价走势向好
Earnings call transcript: ImmuCell Q4 2025 sees positive stock movement
ImmuCell公司报告第四季度销售额为760万美元,将重心转向First Defense
ImmuCell reports Q4 sales of $7.6 million, shifts focus to First Defense
ImmuCell Puts Re-Tain On Pause After FDA Letter - ImmuCell (NASDAQ:ICCC)
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio